位置:首页 > 蛋白库 > DACB2_MYCTU
DACB2_MYCTU
ID   DACB2_MYCTU             Reviewed;         291 AA.
AC   I6Y204;
DT   12-AUG-2020, integrated into UniProtKB/Swiss-Prot.
DT   03-OCT-2012, sequence version 1.
DT   03-AUG-2022, entry version 73.
DE   RecName: Full=D-alanyl-D-alanine carboxypeptidase DacB2 {ECO:0000305};
DE            Short=D,D-carboxypeptidase DacB2 {ECO:0000303|PubMed:22906310};
DE            Short=DD-carboxypeptidase {ECO:0000305};
DE            Short=DD-peptidase {ECO:0000305};
DE            EC=3.4.16.- {ECO:0000269|PubMed:22906310};
DE   Flags: Precursor;
GN   Name=dacB2 {ECO:0000303|PubMed:22138550};
GN   OrderedLocusNames=Rv2911 {ECO:0000312|EMBL:CCP45713.1};
OS   Mycobacterium tuberculosis (strain ATCC 25618 / H37Rv).
OC   Bacteria; Actinobacteria; Corynebacteriales; Mycobacteriaceae;
OC   Mycobacterium; Mycobacterium tuberculosis complex.
OX   NCBI_TaxID=83332;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=ATCC 25618 / H37Rv;
RX   PubMed=9634230; DOI=10.1038/31159;
RA   Cole S.T., Brosch R., Parkhill J., Garnier T., Churcher C.M., Harris D.E.,
RA   Gordon S.V., Eiglmeier K., Gas S., Barry C.E. III, Tekaia F., Badcock K.,
RA   Basham D., Brown D., Chillingworth T., Connor R., Davies R.M., Devlin K.,
RA   Feltwell T., Gentles S., Hamlin N., Holroyd S., Hornsby T., Jagels K.,
RA   Krogh A., McLean J., Moule S., Murphy L.D., Oliver S., Osborne J.,
RA   Quail M.A., Rajandream M.A., Rogers J., Rutter S., Seeger K., Skelton S.,
RA   Squares S., Squares R., Sulston J.E., Taylor K., Whitehead S.,
RA   Barrell B.G.;
RT   "Deciphering the biology of Mycobacterium tuberculosis from the complete
RT   genome sequence.";
RL   Nature 393:537-544(1998).
RN   [2] {ECO:0007744|PubMed:21969609}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21969609; DOI=10.1074/mcp.m111.011627;
RA   Kelkar D.S., Kumar D., Kumar P., Balakrishnan L., Muthusamy B., Yadav A.K.,
RA   Shrivastava P., Marimuthu A., Anand S., Sundaram H., Kingsbury R.,
RA   Harsha H.C., Nair B., Prasad T.S., Chauhan D.S., Katoch K., Katoch V.M.,
RA   Kumar P., Chaerkady R., Ramachandran S., Dash D., Pandey A.;
RT   "Proteogenomic analysis of Mycobacterium tuberculosis by high resolution
RT   mass spectrometry.";
RL   Mol. Cell. Proteomics 10:M111.011627-M111.011627(2011).
RN   [3]
RP   DISRUPTION PHENOTYPE, AND OVEREXPRESSION.
RC   STRAIN=H37Rv;
RX   PubMed=22138550; DOI=10.1016/j.micpath.2011.11.003;
RA   Bourai N., Jacobs W.R. Jr., Narayanan S.;
RT   "Deletion and overexpression studies on DacB2, a putative low molecular
RT   mass penicillin binding protein from Mycobacterium tuberculosis H(37)Rv.";
RL   Microb. Pathog. 52:109-116(2012).
RN   [4]
RP   FUNCTION, CATALYTIC ACTIVITY, AND ACTIVITY REGULATION.
RX   PubMed=22906310; DOI=10.1111/j.1365-2958.2012.08199.x;
RA   Kumar P., Arora K., Lloyd J.R., Lee I.Y., Nair V., Fischer E.,
RA   Boshoff H.I., Barry C.E. III;
RT   "Meropenem inhibits D,D-carboxypeptidase activity in Mycobacterium
RT   tuberculosis.";
RL   Mol. Microbiol. 86:367-381(2012).
RN   [5]
RP   FUNCTION, PATHWAY, AND DISRUPTION PHENOTYPE.
RC   STRAIN=H37Rv;
RX   PubMed=25467937; DOI=10.1016/j.micres.2014.10.002;
RA   Kandasamy S., Narayanan S.;
RT   "Phenotypic characterization of a novel double knockout PknI/DacB2 from
RT   Mycobacterium tuberculosis.";
RL   Microbiol. Res. 170:255-262(2015).
RN   [6] {ECO:0007744|PDB:4P0M}
RP   X-RAY CRYSTALLOGRAPHY (2.00 ANGSTROMS) OF 25-291 OF MUTANT IN COMPLEX WITH
RP   PMSF, FUNCTION, ACTIVITY REGULATION, SUBCELLULAR LOCATION, AND ACTIVE SITE.
RX   PubMed=25551456; DOI=10.1371/journal.pone.0116249;
RA   Prigozhin D.M., Krieger I.V., Huizar J.P., Mavrici D., Waldo G.S.,
RA   Hung L.W., Sacchettini J.C., Terwilliger T.C., Alber T.;
RT   "Subfamily-specific adaptations in the structures of two penicillin-binding
RT   proteins from Mycobacterium tuberculosis.";
RL   PLoS ONE 9:e116249-e116249(2014).
RN   [7] {ECO:0007744|PDB:4RYE}
RP   X-RAY CRYSTALLOGRAPHY (1.90 ANGSTROMS) OF 26-291.
RC   STRAIN=H37Rv;
RA   Cuff M., Tan K., Hatzos-Skintges C., Jedrzejczak R., Sacchettini J.,
RA   Joachimiak A.;
RT   "The crystal structure of D-alanyl-D-alanine carboxypeptidase from
RT   Mycobacterium tuberculosis H37Rv.";
RL   Submitted (DEC-2014) to the PDB data bank.
CC   -!- FUNCTION: Probably cleaves the terminal D-Ala-D-Ala dipeptide of the
CC       peptidoglycan stem peptide (Probable). Shows significant D,D-
CC       carboxypeptidase activity in vitro (PubMed:22906310). Acts on the
CC       synthetic penta-peptide substrate Penta-DAP (L-Ala-gamma-D-Gln-DAP-D-
CC       Ala-D-Ala). Shows also weak activity on Penta-Lys (L-Ala-gamma-Glu-L-
CC       Lys-D-Ala-D-Ala) (PubMed:22906310). The catalytic domain binds weakly
CC       to peptidoglycan in vitro (PubMed:25551456). Plays an important role in
CC       the maintenance of colony morphology and cell wall permeability and
CC       integrity (PubMed:25467937). {ECO:0000269|PubMed:22906310,
CC       ECO:0000269|PubMed:25467937, ECO:0000269|PubMed:25551456,
CC       ECO:0000305|PubMed:22906310}.
CC   -!- ACTIVITY REGULATION: Inhibited by the beta-lactam antibiotic meropenem
CC       (PubMed:22906310). Inhibited by the non-specific inhibitor
CC       phenylmethylsulfonyl fluoride (PMSF) (Probable).
CC       {ECO:0000269|PubMed:22906310, ECO:0000305|PubMed:25551456}.
CC   -!- PATHWAY: Cell wall biogenesis; peptidoglycan biosynthesis.
CC       {ECO:0000305|PubMed:25467937}.
CC   -!- SUBCELLULAR LOCATION: Periplasm {ECO:0000305|PubMed:25551456}.
CC   -!- DISRUPTION PHENOTYPE: Deletion of the gene results in reduced growth in
CC       acidic medium under low oxygen conditions. The mutant shows better
CC       intracellular growth and survival inside THP-1 cells compared to wild-
CC       type and complemented strains. The colony morphology and antibiotic
CC       sensitivity of mutant and wild-type strains are similar
CC       (PubMed:22138550). The double knockout mutant pknI/dacB2 shows smoother
CC       colony morphology on solid agar and exhibits defective biofilm and cord
CC       formation. Double mutant is hypersensitive to cell wall damaging agents
CC       such as lysozyme, malachite green, ethidium bromide and to isoniazid, a
CC       first line anti-TB drug (PubMed:25467937).
CC       {ECO:0000269|PubMed:22138550, ECO:0000269|PubMed:25467937}.
CC   -!- MISCELLANEOUS: Overexpression in Mycobacterium smegmatis results in
CC       reduced growth, an altered colony morphology, and a defect in sliding
CC       motility and biofilm formation. Overexpression of the S69C mutant shows
CC       similar results, indicating that the effects produced are independent
CC       of protein's penicillin binding function.
CC       {ECO:0000269|PubMed:22138550}.
CC   -!- SIMILARITY: Belongs to the peptidase S11 family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AL123456; CCP45713.1; -; Genomic_DNA.
DR   RefSeq; WP_003414736.1; NZ_NVQJ01000006.1.
DR   RefSeq; YP_177914.1; NC_000962.3.
DR   PDB; 4P0M; X-ray; 2.00 A; A=25-291.
DR   PDB; 4RYE; X-ray; 1.90 A; A/B/C/D=26-291.
DR   PDBsum; 4P0M; -.
DR   PDBsum; 4RYE; -.
DR   AlphaFoldDB; I6Y204; -.
DR   SMR; I6Y204; -.
DR   STRING; 83332.Rv2911; -.
DR   PaxDb; I6Y204; -.
DR   PRIDE; I6Y204; -.
DR   DNASU; 887189; -.
DR   GeneID; 45426898; -.
DR   GeneID; 887189; -.
DR   KEGG; mtu:Rv2911; -.
DR   PATRIC; fig|83332.111.peg.3240; -.
DR   TubercuList; Rv2911; -.
DR   eggNOG; COG1686; Bacteria.
DR   OMA; WDIKLTK; -.
DR   PhylomeDB; I6Y204; -.
DR   UniPathway; UPA00219; -.
DR   Proteomes; UP000001584; Chromosome.
DR   GO; GO:0042597; C:periplasmic space; IEA:UniProtKB-SubCell.
DR   GO; GO:0009002; F:serine-type D-Ala-D-Ala carboxypeptidase activity; IEA:InterPro.
DR   GO; GO:0071555; P:cell wall organization; IEA:UniProtKB-KW.
DR   GO; GO:0009252; P:peptidoglycan biosynthetic process; IEA:UniProtKB-UniPathway.
DR   GO; GO:0006508; P:proteolysis; IEA:UniProtKB-KW.
DR   GO; GO:0008360; P:regulation of cell shape; IEA:UniProtKB-KW.
DR   Gene3D; 3.40.710.10; -; 1.
DR   InterPro; IPR012338; Beta-lactam/transpept-like.
DR   InterPro; IPR018044; Peptidase_S11.
DR   InterPro; IPR001967; Peptidase_S11_N.
DR   Pfam; PF00768; Peptidase_S11; 1.
DR   PRINTS; PR00725; DADACBPTASE1.
DR   SUPFAM; SSF56601; SSF56601; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Carboxypeptidase; Cell shape;
KW   Cell wall biogenesis/degradation; Hydrolase; Peptidoglycan synthesis;
KW   Periplasm; Protease; Reference proteome; Signal.
FT   SIGNAL          1..22
FT                   /evidence="ECO:0000255"
FT   CHAIN           23..291
FT                   /note="D-alanyl-D-alanine carboxypeptidase DacB2"
FT                   /id="PRO_5010244966"
FT   ACT_SITE        69
FT                   /note="Acyl-ester intermediate"
FT                   /evidence="ECO:0000305|PubMed:25551456"
FT   ACT_SITE        72
FT                   /note="Proton acceptor"
FT                   /evidence="ECO:0000250|UniProtKB:P0AEB2"
FT   ACT_SITE        124
FT                   /evidence="ECO:0000250|UniProtKB:P0AEB2"
FT   STRAND          43..49
FT                   /evidence="ECO:0007829|PDB:4RYE"
FT   TURN            50..52
FT                   /evidence="ECO:0007829|PDB:4RYE"
FT   STRAND          54..60
FT                   /evidence="ECO:0007829|PDB:4RYE"
FT   HELIX           68..71
FT                   /evidence="ECO:0007829|PDB:4RYE"
FT   HELIX           72..82
FT                   /evidence="ECO:0007829|PDB:4RYE"
FT   STRAND          88..90
FT                   /evidence="ECO:0007829|PDB:4RYE"
FT   HELIX           93..96
FT                   /evidence="ECO:0007829|PDB:4RYE"
FT   STRAND          110..112
FT                   /evidence="ECO:0007829|PDB:4RYE"
FT   HELIX           113..122
FT                   /evidence="ECO:0007829|PDB:4RYE"
FT   HELIX           126..135
FT                   /evidence="ECO:0007829|PDB:4RYE"
FT   HELIX           139..152
FT                   /evidence="ECO:0007829|PDB:4RYE"
FT   STRAND          161..166
FT                   /evidence="ECO:0007829|PDB:4RYE"
FT   HELIX           177..188
FT                   /evidence="ECO:0007829|PDB:4RYE"
FT   HELIX           191..198
FT                   /evidence="ECO:0007829|PDB:4RYE"
FT   STRAND          200..206
FT                   /evidence="ECO:0007829|PDB:4RYE"
FT   STRAND          209..214
FT                   /evidence="ECO:0007829|PDB:4RYE"
FT   HELIX           219..222
FT                   /evidence="ECO:0007829|PDB:4RYE"
FT   STRAND          226..234
FT                   /evidence="ECO:0007829|PDB:4RYE"
FT   TURN            235..237
FT                   /evidence="ECO:0007829|PDB:4RYE"
FT   STRAND          238..247
FT                   /evidence="ECO:0007829|PDB:4RYE"
FT   STRAND          250..259
FT                   /evidence="ECO:0007829|PDB:4RYE"
FT   HELIX           268..281
FT                   /evidence="ECO:0007829|PDB:4RYE"
FT   STRAND          288..290
FT                   /evidence="ECO:0007829|PDB:4RYE"
SQ   SEQUENCE   291 AA;  29747 MW;  BE6282F8DDAFB3B8 CRC64;
     MRKLMTATAA LCACAVTVSA GAAWADADVQ PAGSVPIPDG PAQTWIVADL DSGQVLAGRD
     QNVAHPPAST IKVLLALVAL DELDLNSTVV ADVADTQAEC NCVGVKPGRS YTARQLLDGL
     LLVSGNDAAN TLAHMLGGQD VTVAKMNAKA ATLGATSTHA TTPSGLDGPG GSGASTAHDL
     VVIFRAAMAN PVFAQITAEP SAMFPSDNGE QLIVNQDELL QRYPGAIGGK TGYTNAARKT
     FVGAAARGGR RLVIAMMYGL VKEGGPTYWD QAATLFDWGF ALNPQASVGS L
 
 
维奥蛋白资源库 - 中文蛋白资源 CopyRight © 2010-2024